Compare FDMT & AROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FDMT | AROW |
|---|---|---|
| Founded | 2013 | 1851 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 391.8M | 442.9M |
| IPO Year | 2020 | N/A |
| Metric | FDMT | AROW |
|---|---|---|
| Price | $10.99 | $31.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | ★ $30.33 | $28.00 |
| AVG Volume (30 Days) | ★ 767.4K | 61.8K |
| Earning Date | 11-10-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 3.60% |
| EPS Growth | N/A | ★ 5.41 |
| EPS | N/A | ★ 2.07 |
| Revenue | $120,000.00 | ★ $146,817,000.00 |
| Revenue This Year | $21,181.08 | $25.16 |
| Revenue Next Year | $162.43 | $9.99 |
| P/E Ratio | ★ N/A | $15.59 |
| Revenue Growth | ★ 605.88 | 7.84 |
| 52 Week Low | $2.24 | $22.72 |
| 52 Week High | $12.34 | $32.47 |
| Indicator | FDMT | AROW |
|---|---|---|
| Relative Strength Index (RSI) | 53.25 | 63.42 |
| Support Level | $10.30 | $30.54 |
| Resistance Level | $11.50 | $32.00 |
| Average True Range (ATR) | 0.70 | 1.12 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 56.85 | 94.44 |
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.